Global Alzheimer's Disease Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	168 Pages	TechNavio	November, 2023	INF18379442

Best Price Guarantee
Price	from $2,500
Length	168 Pages
Publisher	TechNavio
Published Date	November, 2023
SKU	INF18379442

Global Alzheimer's Disease Therapeutics Market 2024-2028

The alzheimer's disease therapeutics market is forecasted to grow by USD 5.41 bn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the alzheimer's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability, research, and development of novel biomarkers, increasing awareness of Alzheimers disease, and strong pipeline coupled with approval of therapeutics.

Technavio's alzheimer's disease therapeutics market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
E-commerce pharmacy

By Drug Class

Cholinesterase inhibitors
N-methyl-D-aspartate receptor antagonist
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of regenerative therapies as one of the prime reasons driving the Alzheimer's disease therapeutics market growth during the next few years. Also, increasing funding for therapeutics discovery and availability of highly sensitive diagnostic modalities will lead to sizable demand in the market.

The report on the alzheimer's disease therapeutics market covers the following areas:

Alzheimer's disease therapeutics market sizing
Alzheimer's disease therapeutics market forecast
Alzheimer's disease therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading alzheimer's disease therapeutics market vendors that include AB Science SA, AbbVie Inc., AgeneBio Inc., Biogen Inc., Cipla Ltd., Curasia Medilab, Denali Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Grifols SA, H Lundbeck AS, Johnson and Johnson, Lifecare Neuro Products Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., Psycogen Captab, Solco Healthcare, Teva Pharmaceutical Industries Ltd., and Aurobindo Pharma Ltd.. Also, the alzheimer's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by Distribution Channel
  - Table Executive Summary - Chart on Market Segmentation by Drug Class
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global Alzheimers disease therapeutics market 2018 - 2022
  - Table Historic Market Size - Data Table on global Alzheimers disease therapeutics market 2018 - 2022 ($ million)
- Distribution Channel Segment Analysis 2018 - 2022
  - Table Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- Drug class Segment Analysis 2018 - 2022
  - Table Historic Market Size - Drug class Segment 2018 - 2022 ($ million)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size - Country Segment 2018 - 2022 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by Distribution Channel
- Market segments
  - Table Chart on Distribution Channel - Market share 2023-2028 (%)
  - Table Data Table on Distribution Channel - Market share 2023-2028 (%)
- Comparison by Distribution Channel
  - Table Chart on Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacy - Market size and forecast 2023-2028
  - Table Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Retail pharmacy - Market size and forecast 2023-2028
  - Table Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- E-commerce pharmacy - Market size and forecast 2023- 2028
  - Table Chart on E-commerce pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on E-commerce pharmacy - Market size and forecast 2023-2028 ($ million)
  - Table Chart on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
  - Table Data Table on E-commerce pharmacy - Year-over-year growth 2023-2028 (%)
- Market opportunity by Distribution Channel
  - Table Market opportunity by Distribution Channel ($ million)
  - Table Data Table on Market opportunity by Distribution Channel ($ million)
Market Segmentation by Drug Class
- Market segments
  - Table Chart on Drug Class - Market share 2023-2028 (%)
  - Table Data Table on Drug Class - Market share 2023-2028 (%)
- Comparison by Drug Class
  - Table Chart on Comparison by Drug Class
  - Table Data Table on Comparison by Drug Class
- Cholinesterase inhibitors - Market size and forecast 2023-2028
  - Table Chart on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Cholinesterase inhibitors - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Cholinesterase inhibitors - Year-over-year growth 2023-2028 (%)
- N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028
  - Table Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2023- 2028 ($ million)
  - Table Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023-2028 (%)
  - Table Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2023- 2028 (%)
- Others - Market size and forecast 2023-2028
  - Table Chart on Others - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Others - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Others - Year-over-year growth 2023-2028 (%)
- Market opportunity by Drug Class
  - Table Market opportunity by Drug Class ($ million)
  - Table Data Table on Market opportunity by Drug Class ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ million)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Canada - Market size and forecast 2023-2028
  - Table Chart on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Canada - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Japan - Market size and forecast 2023-2028
  - Table Chart on Japan - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Japan - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Japan - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Availability, research, and development of novel biomarkers
  - Increasing awareness of Alzheimers disease
  - Strong pipeline coupled with approval of therapeutics
- Market challenges
  - High cost of therapeutics development
  - Drug failure in clinical trials
  - Challenges associated with diagnosis of Alzheimers disease
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Emergence of regenerative therapies
  - Increasing funding for therapeutics discovery
  - Availability of highly sensitive diagnostic modalities
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AB Science SA
  - Table AB Science SA - Overview
  - Table AB Science SA - Product / Service
  - Table AB Science SA - Key offerings
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- AgeneBio Inc.
  - Table AgeneBio Inc. - Overview
  - Table AgeneBio Inc. - Product / Service
  - Table AgeneBio Inc. - Key offerings
- Aurobindo Pharma Ltd.
  - Table Aurobindo Pharma Ltd. - Overview
  - Table Aurobindo Pharma Ltd. - Product / Service
  - Table Aurobindo Pharma Ltd. - Key offerings
- Cipla Ltd.
  - Table Cipla Ltd. - Overview
  - Table Cipla Ltd. - Business segments
  - Table Cipla Ltd. - Key news
  - Table Cipla Ltd. - Key offerings
  - Table Cipla Ltd. - Segment focus
- Eisai Co. Ltd.
  - Table Eisai Co. Ltd. - Overview
  - Table Eisai Co. Ltd. - Business segments
  - Table Eisai Co. Ltd. - Key offerings
  - Table Eisai Co. Ltd. - Segment focus
- Eli Lilly and Co.
  - Table Eli Lilly and Co. - Overview
  - Table Eli Lilly and Co. - Product / Service
  - Table Eli Lilly and Co. - Key news
  - Table Eli Lilly and Co. - Key offerings
- Grifols SA
  - Table Grifols SA - Overview
  - Table Grifols SA - Business segments
  - Table Grifols SA - Key offerings
  - Table Grifols SA - Segment focus
- H Lundbeck AS
  - Table H Lundbeck AS - Overview
  - Table H Lundbeck AS - Product / Service
  - Table H Lundbeck AS - Key offerings
- Johnson and Johnson
  - Table Johnson and Johnson - Overview
  - Table Johnson and Johnson - Business segments
  - Table Johnson and Johnson - Key news
  - Table Johnson and Johnson - Key offerings
  - Table Johnson and Johnson - Segment focus
- Lupin Ltd.
  - Table Lupin Ltd. - Overview
  - Table Lupin Ltd. - Product / Service
  - Table Lupin Ltd. - Key news
  - Table Lupin Ltd. - Key offerings
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Solco Healthcare
  - Table Solco Healthcare - Overview
  - Table Solco Healthcare - Product / Service
  - Table Solco Healthcare - Key offerings
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations